Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal Execs Skip Bonuses As SEC Subpoenas Compensation Information

Executive Summary

Cardinal Health's executives will go without a bonus for fiscal 2004 after the company's operating earnings fell short of goals for the year

You may also be interested in...



Cardinal ethics and compliance

Cardinal Health appoints Daniel Walsh to newly created position of exec VP-chief ethics and compliance officer, effective May 18. Walsh comes to the wholesaler from broadband supplier Scientific-Atlanta, where he was VP-chief compliance officer. Cardinal created chief compliance officer and chief accounting officer positions following an internal review that was prompted by a Securities & Exchange Commission investigation into its revenue classification practices (1"The Pink Sheet" Nov. 1, 2004, p. 4). Also as part of the personnel changes, Jeffrey Henderson became CFO May 15 (2"The Pink Sheet" May 2, 2005, In Brief)...

Cardinal ethics and compliance

Cardinal Health appoints Daniel Walsh to newly created position of exec VP-chief ethics and compliance officer, effective May 18. Walsh comes to the wholesaler from broadband supplier Scientific-Atlanta, where he was VP-chief compliance officer. Cardinal created chief compliance officer and chief accounting officer positions following an internal review that was prompted by a Securities & Exchange Commission investigation into its revenue classification practices (1"The Pink Sheet" Nov. 1, 2004, p. 4). Also as part of the personnel changes, Jeffrey Henderson became CFO May 15 (2"The Pink Sheet" May 2, 2005, In Brief)...

Cardinal Fee-For-Service Ultimatum Is Serious, CEO Says

Cardinal is ready to make good on its threat to cut off drug distribution services for products not covered under a fee-for-service distribution agreement by the end of March, CEO Bob Walter said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel